HIV/AIDS and Medical Marijuana: What Patients in the US Need to Know – Med Card District
Cannabis therapy for HIV patients shows promise for appetite stimulation and neuropathic pain management, but requires careful consideration of drug interactions with antiretroviral therapy. Clinical evidence supports modest but meaningful improvements…
Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief
This review of cannabinoid therapy neuropathic pain examines a 2022 meta-analysis of eight randomized controlled trials involving 1,051 patients. The findings showed significant improvements in sleep quality and pain intensity. The study highlights…
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
Cannabis medicines neuropathic pain evidence suggests potential benefits for nerve pain relief. However, study limitations like small samples and short durations hinder firm conclusions. More rigorous trials are needed to clarify efficacy and safety.
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Neuropathic pain cannabis treatment shows promise but remains inconclusive due to study limitations. Trials reveal mixed evidence with no definitive winners yet. Careful dosing and further research are essential for clinical guidance.
Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
Neurocutaneous dysesthesia (ND) is characterized by abnormal skin sensations such as pruritus or burning without an underlying skin condition. It is caused b...
Neuropathic Pain Severity Is Associated With Opioid Use in Adults With Traumatic Spinal Cord Injury: A Spinal Cord Injury Model System Study.
A new study of 283 spinal cord injury patients reveals that neuropathic pain severity predicts opioid use, while employment status reduces opioid dependence risk by 33%. The research highlights complex medication patterns including cannabis combinations…
Evaluating CB2 Receptor Agonist Effects on Neuropathic Pain
This study highlights cb2 receptor agonist neuropathic pain treatment as a promising approach to reduce both evoked and spontaneous pain. The preclinical findings suggest potential benefits for managing neuropathic pain. Further human studies are needed…
Cannabis-Based Medicines for Chronic Neuropathic Pain in Adults
The 2025 Cochrane review on cannabis-based medicines neuropathic pain provides the most rigorous analysis of cannabinoid effectiveness for chronic nerve pain. This systematic review update incorporates recent trial data to inform evidence-based clinical…
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review
This systematic review highlights cannabinoids diabetic neuropathy pain relief, showing significant benefits in three of four trials. THC-containing products demonstrated the strongest efficacy for diabetic nerve pain. These findings provide…
Study: Minor Cannabinoids Show Distinct Effects on Pain-Sensing Neurons
Minor cannabinoids pain management research highlights their distinct effects on pain-sensing neurons. These compounds may offer new therapeutic options beyond THC and CBD. Understanding their role is crucial for advancing cannabinoid therapies.